EXEL SEC filings (2026)
CIK 939767 · Biological Products, (No Diagnostic Substances) (SIC 2836) · incorporated in DE · fiscal year ends in January
2,513 filings on EDGAR since 2000 · 27 annual, 86 quarterly, 344 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 118-K8-K · Other events
August 2026
- Aug 318-K8-K · Other events
- Aug 10Insider saleBeckerle Mary C (Director) sold 9,812 shares for $527K at $53.66 under a 10b5-1 plan
- Aug 5EarningsEarnings release — EPS $0.82 vs $0.75 est. (+9.3%); revenue $628.7M (+11% y/y) 7.9%
- Aug 5ReportQuarterly report, Q2 2026 — revenue $628.7M (+11% y/y), net income $212.1M, EPS $0.82
June 2026
May 2026
- May 298-K8-K · Directors or officers; compensation; Shareholder vote results
- May 26Insider saleAftab Dana (EVP, Research and Development) sold 43,451 shares for $2.2M at $50.35
- May 20Insider saleHaley Patrick J. (EVP, Commercial) sold 32,110 shares for $1.6M at $49.81
- May 18Insider saleSenner Christopher J. (EVP and CFO) sold 34,901 shares for $1.7M at $50.00
- May 18Insider saleHefti Brenda (SVP and General Counsel) sold 6,625 shares for $333K at $50.21 under a 10b5-1 plan
- May 7Insider salePOSTE GEORGE (Director) sold 60,000 shares for $2.7M at $45.71
- May 7Insider saleFreire Maria C (Director) sold 20,634 shares for $949K at $46.00
- May 7Insider saleBeckerle Mary C (Director) sold 7,712 shares for $374K at $48.45
- May 5EarningsEarnings release — EPS $0.79 vs $0.67 est. (+17.9%); revenue $610.8M (+10% y/y) 9.6%
- May 5ReportQuarterly report, Q1 2026 — revenue $610.8M (+10% y/y), net income $210.5M, EPS $0.79
April 2026
- Apr 17ProxyProxy · Additional proxy materials
- Apr 15ProxyProxy · Additional proxy materials
- Apr 15ProxyProxy · Proxy statement
February 2026
- Feb 24Insider saleAftab Dana (EVP, Research and Development) sold 47,918 shares for $2.1M at $44.50
- Feb 19Insider saleAftab Dana (EVP, Research and Development) sold 29,873 shares for $1.3M at $44.35
- Feb 18Insider saleWYSZOMIERSKI JACK L (Director) sold 99,574 shares for $4.4M at $44.01 under a 10b5-1 plan
- Feb 18Insider saleSmith Julie (Director) sold 64,117 shares for $2.8M at $44.30–$44.50
- Feb 18Insider saleHefti Brenda (SVP and General Counsel) sold 18,669 shares for $822K at $44.01 under a 10b5-1 plan
- Feb 17Insider saleHaley Patrick J. (EVP, Commercial) sold 67,814 shares for $3.0M at $43.50–$43.84
- Feb 17Insider saleSmith Julie (Director) sold 42,422 shares for $1.8M at $43.33
- Feb 17Insider saleSenner Christopher J. (EVP and CFO) sold 30,617 shares for $1.3M at $43.67
- Feb 13Insider saleSenner Christopher J. (EVP and CFO) sold 34,278 shares for $1.5M at $43.00
- Feb 13Insider saleOliver Bob (Director) sold 30,250 shares for $1.3M at $43.61–$43.90
- Feb 13Insider saleEckhardt Sue Gail (Director) sold 3,856 shares for $169K at $43.79 under a 10b5-1 plan
- Feb 10EarningsEarnings release — EPS $0.88 vs $0.66 est. (+29.4%); revenue $598.7M (+6% y/y) 0.1%
- Feb 10ReportAnnual report, FY2025 — revenue $2.32B (+7% y/y), net income $782.6M, EPS $2.78
January 2026
November 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $31.8M in 21 sales and bought nothing on the open market; 53 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Aug 10, 2026Form 4 | Beckerle Mary CDirectorSold · $527K · 9,812 sh · 10b5-1 |
| Jun 1, 2026Form 4 | Eckhardt Sue GailDirectorSold · $492K · 9,812 sh · 10b5-1 |
| Jun 1, 2026Form 4 | WYSZOMIERSKI JACK LDirectorSold · $198K · 3,925 sh · 10b5-1 |
| May 26, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentSold · $2.2M · 43,451 sh |
| May 20, 2026Form 4 | Haley Patrick J.EVP, CommercialSold · $1.6M · 32,110 sh |
| May 18, 2026Form 4 | Senner Christopher J.EVP and CFOSold · $1.7M · 34,901 sh |
| May 18, 2026Form 4 | Hefti BrendaSVP and General CounselSold · $333K · 6,625 sh · 10b5-1 |
| May 7, 2026Form 4 | POSTE GEORGEDirectorSold · $2.7M · 60,000 sh |
| May 7, 2026Form 4 | Freire Maria CDirectorSold · $949K · 20,634 sh |
| May 7, 2026Form 4 | Beckerle Mary CDirectorSold · $374K · 7,712 sh |
| Feb 24, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentSold · $2.1M · 47,918 sh |
| Feb 19, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentSold · $1.3M · 29,873 sh |
| Feb 18, 2026Form 4 | WYSZOMIERSKI JACK LDirectorSold · $4.4M · 99,574 sh · 10b5-1 |
| Feb 18, 2026Form 4 | Smith JulieDirectorSold · $2.8M · 64,117 sh |
| Feb 18, 2026Form 4 | Hefti BrendaSVP and General CounselSold · $822K · 18,669 sh · 10b5-1 |
| Feb 17, 2026Form 4 | Haley Patrick J.EVP, CommercialSold · $3.0M · 67,814 sh |
| Feb 17, 2026Form 4 | Smith JulieDirectorSold · $1.8M · 42,422 sh |
| Feb 17, 2026Form 4 | Senner Christopher J.EVP and CFOSold · $1.3M · 30,617 sh |
| Feb 13, 2026Form 4 | Senner Christopher J.EVP and CFOSold · $1.5M · 34,278 sh |
| Feb 13, 2026Form 4 | Oliver BobDirectorSold · $1.3M · 30,250 sh |
| Feb 13, 2026Form 4 | Eckhardt Sue GailDirectorSold · $169K · 3,856 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 53 transactions
| Date | Insider |
|---|---|
| May 27, 2026Form 4 | JOHNSON DAVID EDWARD, Caligan Partners LP2 filersAward · Option (right to buy) · $0 · 19,133 sh |
| May 27, 2026Form 4 | POSTE GEORGEDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | WYSZOMIERSKI JACK LDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | Oliver BobDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | Beckerle Mary CDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | Freire Maria CDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | Smith JulieDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | Eckhardt Sue GailDirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | Heyman Tomas J.DirectorAward · $0 · 8,367 sh |
| May 27, 2026Form 4 | PAPADOPOULOS STELIOSDirectorAward · $0 · 8,367 sh |
| May 18, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorGift · $0 · 248,094 sh |
| May 15, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorTax withholding · $6.6M · 128,497 sh |
| May 15, 2026Form 4 | Senner Christopher J.EVP and CFOTax withholding · $2.1M · 40,892 sh |
| May 15, 2026Form 4 | Haley Patrick J.EVP, CommercialTax withholding · $1.7M · 33,265 sh |
| May 15, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentTax withholding · $1.6M · 30,578 sh |
| May 15, 2026Form 4 | Hefti BrendaSVP and General CounselTax withholding · $328K · 6,411 sh · 10b5-1 |
| May 7, 2026Form 4 | Freire Maria CDirectorExercise or conversion · $408K · 20,634 sh |
| May 7, 2026Form 4 | Beckerle Mary CDirectorExercise or conversion · $90K · 3,856 sh |
| May 7, 2026Form 4 | Freire Maria CDirectorExercise or conversion · Option (right to buy) · $0 · 20,634 sh |
| May 7, 2026Form 4 | Beckerle Mary CDirectorExercise or conversion · Option (right to buy) · $0 · 3,856 sh |
| May 6, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorGift · $0 · 109,676 sh |
| Feb 26, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorAward · $0 · 160,437 sh |
| Feb 26, 2026Form 4 | Senner Christopher J.EVP and CFOAward · $0 · 52,018 sh |
| Feb 26, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentAward · $0 · 52,018 sh |
| Feb 26, 2026Form 4 | Haley Patrick J.EVP, CommercialAward · $0 · 40,459 sh |
| Feb 26, 2026Form 4 | Hefti BrendaSVP and General CounselAward · $0 · 23,119 sh |
| Feb 24, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorGift · $0 · 100,278 sh |
| Feb 18, 2026Form 4 | Smith JulieDirectorExercise or conversion · $1.3M · 64,117 sh |
| Feb 18, 2026Form 4 | WYSZOMIERSKI JACK LDirectorExercise or conversion · $408K · 20,634 sh · 10b5-1 |
| Feb 18, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorGift · $0 · 250,188 sh |
| Feb 18, 2026Form 4 | Smith JulieDirectorExercise or conversion · Option (right to buy) · $0 · 64,117 sh |
| Feb 18, 2026Form 4 | WYSZOMIERSKI JACK LDirectorExercise or conversion · Option (right to buy) · $0 · 20,634 sh · 10b5-1 |
| Feb 17, 2026Form 4 | Smith JulieDirectorExercise or conversion · $772K · 42,422 sh |
| Feb 17, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorGift · $0 · 501,472 sh |
| Feb 17, 2026Form 4 | Smith JulieDirectorExercise or conversion · Option (right to buy) · $0 · 42,422 sh |
| Feb 15, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorTax withholding · $5.3M · 120,390 sh |
| Feb 15, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentTax withholding · $1.7M · 39,205 sh |
| Feb 15, 2026Form 4 | Senner Christopher J.EVP and CFOTax withholding · $1.6M · 35,870 sh |
| Feb 15, 2026Form 4 | Haley Patrick J.EVP, CommercialTax withholding · $1.4M · 31,483 sh |
| Feb 15, 2026Form 4 | Hefti BrendaSVP and General CounselTax withholding · $238K · 5,430 sh · 10b5-1 |
| Feb 13, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorTax withholding · $16.2M · 369,606 sh |
| Feb 13, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorExercise or conversion · $10.5M · 494,700 sh |
| Feb 13, 2026Form 4 | Oliver BobDirectorExercise or conversion · $175K · 9,088 sh |
| Feb 13, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorExercise or conversion · Option (right to buy) · $0 · 494,700 sh |
| Feb 13, 2026Form 4 | Oliver BobDirectorExercise or conversion · Option (right to buy) · $0 · 9,088 sh |
| Jan 15, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorTax withholding · $6.3M · 139,524 sh |
| Jan 15, 2026Form 4 | Senner Christopher J.EVP and CFOTax withholding · $1.8M · 40,459 sh |
| Jan 15, 2026Form 4 | Haley Patrick J.EVP, CommercialTax withholding · $1.5M · 32,332 sh |
| Jan 15, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentTax withholding · $1.2M · 27,254 sh |
| Jan 15, 2026Form 4 | MORRISSEY MICHAELPresident and CEO · DirectorAward · $0 · 548,073 sh |
| Jan 15, 2026Form 4 | Senner Christopher J.EVP and CFOAward · $0 · 149,474 sh |
| Jan 15, 2026Form 4 | Haley Patrick J.EVP, CommercialAward · $0 · 139,508 sh |
| Jan 15, 2026Form 4 | Aftab DanaEVP, Research and DevelopmentAward · $0 · 119,578 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 13 filings
| Filed | What it is |
|---|---|
| Sep 11, 20268-K | Other events |
| Aug 31, 20268-K | Other events |
| Aug 5, 202610-Q | Quarterly report, Q2 2026 — revenue $628.7M (+11% y/y), net income $212.1M, EPS $0.82 |
| Aug 5, 20268-K | Earnings release — EPS $0.82 vs $0.75 est. (+9.3%); revenue $628.7M (+11% y/y) 7.9% |
| May 29, 20268-K | Directors or officers; compensation; Shareholder vote results |
| May 5, 202610-Q | Quarterly report, Q1 2026 — revenue $610.8M (+10% y/y), net income $210.5M, EPS $0.79 |
| May 5, 20268-K | Earnings release — EPS $0.79 vs $0.67 est. (+17.9%); revenue $610.8M (+10% y/y) 9.6% |
| Apr 17, 2026DEFA14A | Additional proxy materials |
| Apr 15, 2026DEFA14A | Additional proxy materials |
| Apr 15, 2026DEF 14A | Proxy statement |
| Feb 10, 202610-K | Annual report, FY2025 — revenue $2.32B (+7% y/y), net income $782.6M, EPS $2.78 |
| Feb 10, 20268-K | Earnings release — EPS $0.88 vs $0.66 est. (+29.4%); revenue $598.7M (+6% y/y) 0.1% |
| Jan 12, 20268-K | Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026Results of operations |
2025 · 17 filings
| Filed | What it is |
|---|---|
| Nov 7, 20258-K | Directors or officers; compensation; Other events |
| Nov 4, 202510-Q | Quarterly report, Q3 2025 — revenue $597.8M (+11% y/y), net income $193.6M, EPS $0.69 |
| Nov 4, 20258-K | Earnings release — EPS $0.67 vs $0.59 est. (+13.6%); revenue $597.8M (+11% y/y) 6.5% |
| Aug 29, 20258-K | Directors or officers; compensation |
| Jul 28, 202510-Q | Quarterly report, Q2 2025 — revenue $568.3M (−11% y/y), net income $184.8M, EPS $0.65 |
| Jul 28, 20258-K | Earnings release — EPS $0.65 vs $0.58 est. (+12.1%); revenue $568.3M (−11% y/y) 16.8% |
| Jun 2, 20258-K | Shareholder vote results |
| May 13, 202510-Q | Quarterly report, Q1 2025 — revenue $555.4M (+31% y/y), net income $159.6M, EPS $0.55 |
| May 13, 20258-K | Earnings release — EPS $0.53 vs $0.35 est. (+51.4%); revenue $555.4M (+31% y/y) 20.8% |
| Apr 16, 2025ARS | Annual report to shareholders |
| Apr 16, 2025DEFA14A | Additional proxy materials |
| Apr 16, 2025DEF 14A | Proxy statement |
| Mar 31, 20258-K | Directors or officers; compensation |
| Feb 21, 20258-K | Other events |
| Feb 11, 202510-K | Annual report, FY2024 — revenue $2.17B (+18% y/y), net income $521.3M, EPS $1.76 |
| Feb 11, 20258-K | Earnings release — EPS $0.48 vs $0.45 est. (+6.7%); revenue $566.8M (+18% y/y) 0.0% |
| Jan 13, 20258-K | Results of operations |
2024 · 18 filings
| Filed | What it is |
|---|---|
| Oct 29, 202410-Q | Quarterly report, Q3 2024 — revenue $539.5M (+14% y/y), net income $118.0M, EPS $0.40 |
| Oct 29, 20248-K | Earnings release — EPS $0.40 vs $0.36 est. (+11.1%); revenue $539.5M (+14% y/y) 12.9% |
| Oct 15, 20248-K | Other events |
| Oct 15, 20248-K | Other events |
| Aug 6, 202410-Q | Quarterly report, Q2 2024 — revenue $637.2M (+36% y/y), net income $226.1M, EPS $0.77 |
| Aug 6, 20248-K | Earnings release — EPS $0.75 vs $0.31 est. (+141.9%); revenue $637.2M (+36% y/y) 13.1% |
| Jun 3, 20248-K | Directors or officers; compensation; Shareholder vote results |
| May 20, 20248-K | Other events |
| May 10, 20248-K | Other events |
| Apr 30, 202410-Q | Quarterly report, Q1 2024 — revenue $425.2M (+4% y/y), net income $37.3M, EPS $0.12 |
| Apr 30, 20248-K | Earnings release — EPS $0.12 vs $0.22 est. (−45.5%); revenue $425.2M (+4% y/y) 6.5% |
| Apr 18, 2024ARS | Annual report to shareholders |
| Apr 18, 2024DEFA14A | Additional proxy materials |
| Apr 18, 2024DEF 14A | Proxy statement |
| Mar 29, 20248-K | Directors or officers; compensation |
| Feb 6, 202410-K | Annual report, FY2023 — revenue $1.83B (+14% y/y), net income $207.8M, EPS $0.65 |
| Feb 6, 20248-K | Earnings release — EPS $0.27 vs $0.25 est. (+8.0%); revenue $479.7M (+13% y/y) 7.6% |
| Jan 8, 20248-K | Results of operations; Exit or disposal costs; Directors or officers; compensation; Other events |
2023 · 38 filings — 14 × 8-K, 8 × DFAN14A, 7 × DEFA14A and 5 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202310-Q | Quarterly report, Q3 2023 — revenue $471.9M (+15% y/y), net income $1.0M, EPS $0.00 |
| Aug 1, 202310-Q | Quarterly report, Q2 2023 — revenue $469.8M (+12% y/y), net income $81.2M, EPS $0.25 |
| May 17, 2023DEFA14A | Additional proxy materials |
| May 15, 2023DFAN14A | EXELIXIS, INC. |
| May 15, 2023DEFA14A | Additional proxy materials |
| May 11, 2023DFAN14A | EXELIXIS, INC. |
| May 9, 202310-Q | Quarterly report, Q1 2023 — revenue $408.8M (+15% y/y), net income $40.0M, EPS $0.12 |
| May 8, 2023DFAN14A | EXELIXIS, INC. |
| May 8, 2023DFAN14A | EXELIXIS, INC. |
| May 8, 2023DEFA14A | Additional proxy materials |
| May 3, 2023DFAN14A | EXELIXIS, INC. |
| May 3, 2023DEFC14A | EXELIXIS, INC. |
| May 2, 2023DEFA14A | Additional proxy materials |
| May 2, 2023ARS | Annual report to shareholders |
| May 1, 2023DEFA14A | Additional proxy materials |
| May 1, 2023DEFC14A | Proxy statements |
| Apr 25, 2023DFAN14A | EXELIXIS, INC. |
| Apr 24, 2023DFAN14A | Proxy statements |
| Apr 17, 2023PREC14A | Proxy statements |
| Apr 13, 2023DEFA14A | Additional proxy materials |
| Apr 6, 2023PREC14A | EXELIXIS, INC. |
| Apr 6, 2023DEFA14A | Additional proxy materials |
| Apr 5, 2023DFAN14A | EXELIXIS, INC. |
| Feb 7, 202310-K | Annual report, FY2022 — revenue $1.61B (+12% y/y), net income $182.3M, EPS $0.56 |
14 current reports (8-K) not listed; the year is on EDGAR.
2022 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 202210-Q | Quarterly report, Q3 2022 — revenue $411.7M (+25% y/y), net income $73.2M, EPS $0.23 |
| Aug 9, 202210-Q | Quarterly report, Q2 2022 — revenue $419.4M (+9% y/y), net income $70.7M, EPS $0.22 |
| May 10, 202210-Q | Quarterly report, Q1 2022 — revenue $356.0M (+32% y/y), net income $68.6M, EPS $0.21 |
| Apr 14, 2022DEFA14A | Additional proxy materials |
| Apr 14, 2022DEF 14A | Proxy statement |
| Feb 18, 202210-K | Annual report, FY2021 — revenue $1.43B (+45% y/y), net income $231.1M, EPS $0.72 |
11 current reports (8-K) not listed; the year is on EDGAR.
2021 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 2, 202110-Q | Quarterly report, Q3 2021 — revenue $328.4M (+42% y/y), net income $38.2M, EPS $0.12 |
| Aug 5, 202110-Q | Quarterly report, Q2 2021 — revenue $385.2M (+48% y/y), net income $96.1M |
| May 6, 202110-Q | Quarterly report, Q1 2021 — revenue $270.2M (+19% y/y), net income $1.6M, EPS $0.00 |
| Apr 15, 2021DEFA14A | Additional proxy materials |
| Apr 15, 2021DEF 14A | Proxy statement |
| Feb 11, 202110-K | Annual report, FY2020 — revenue $987.5M (+2% y/y), net income $111.8M, EPS $0.35 |
13 current reports (8-K) not listed; the year is on EDGAR.
2020 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 5, 202010-Q | Quarterly report, Q3 2020 — revenue $231.1M (−15% y/y), net income −$32.0M, EPS −$0.10 |
| Aug 6, 202010-Q | Quarterly report, Q2 2020 — revenue $259.5M (+8% y/y), net income $66.8M, EPS $0.21 |
| May 5, 202010-Q | Quarterly report, Q1 2020 — revenue $226.9M (+5% y/y), net income $48.6M, EPS $0.15 |
| Apr 9, 2020DEFA14A | Additional proxy materials |
| Apr 9, 2020DEF 14A | Proxy statement |
| Feb 25, 202010-K | Annual report, FY2019 — revenue $967.8M (+13% y/y), net income $321.0M, EPS $1.02 |
10 current reports (8-K) not listed; the year is on EDGAR.
2019 · 22 filings — 13 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Oct 30, 201910-Q | Quarterly report, Q3 2019 — revenue $271.7M (+21% y/y), net income $97.5M, EPS $0.31 |
| Jul 31, 201910-Q | Quarterly report, Q2 2019 — revenue $240.3M (+29% y/y), net income $79.0M, EPS $0.25 |
| May 8, 2019DEFA14A | Additional proxy materials |
| May 8, 2019DEFA14A | Additional proxy materials |
| May 1, 201910-Q | Quarterly report, Q1 2019 — revenue $215.5M (+1% y/y), net income $75.8M, EPS $0.24 |
| Apr 11, 2019DEFA14A | Additional proxy materials |
| Apr 11, 2019DEF 14A | Proxy statement |
| Mar 28, 2019PRE 14A | Preliminary proxy statement |
| Feb 22, 201910-K | Annual report, FY2018 — revenue $853.8M (+89% y/y), net income $690.1M, EPS $2.21 |
13 current reports (8-K) not listed; the year is on EDGAR.
2018 · 13 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201810-Q | Quarterly report, Q3 2018 — revenue $225.4M (+48% y/y), net income $126.6M, EPS $0.41 |
| Aug 1, 201810-Q | Quarterly report, Q2 2018 — revenue $186.1M (+88% y/y), net income $87.5M, EPS $0.28 |
| May 2, 201810-Q | Quarterly report, Q1 2018 — revenue $213.7M (+164% y/y), net income $115.9M, EPS $0.37 |
| Apr 12, 2018DEFA14A | Additional proxy materials |
| Apr 12, 2018DEF 14A | Proxy statement |
| Feb 26, 201810-K | Annual report, FY2017 — revenue $452.5M (+136% y/y), net income $154.2M, EPS $0.49 |
7 current reports (8-K) not listed; the year is on EDGAR.
2017 · 19 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms
| Filed | What it is |
|---|---|
| Nov 1, 201710-Q | Quarterly report, Q3 2017 — revenue $152.5M (+145% y/y), net income $81.4M, EPS $0.26 |
| Aug 2, 201710-Q | Quarterly report, Q2 2017 — revenue $99.0M (+173% y/y), net income $17.7M, EPS $0.06 |
| Jul 14, 201710-Q/A | Quarterly report, amended |
| May 11, 2017DEFA14A | Additional proxy materials |
| May 1, 201710-Q | Quarterly report, Q1 2017 — revenue $80.9M (+424% y/y), net income $16.7M, EPS $0.05 |
| Apr 13, 2017DEFA14A | Additional proxy materials |
| Apr 13, 2017DEF 14A | Proxy statement |
| Feb 27, 201710-K | Annual report, FY2016 — revenue $191.5M (+415% y/y), net income −$70.2M |
11 current reports (8-K) not listed; the year is on EDGAR.
2016 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 19 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 25 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2013 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2012 · 23 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 26 filings — 18 × 8-K, 3 × 10-Q, 2 × 8-K/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2010 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2009 · 21 filings — 12 × 8-K, 3 × 10-Q, 2 × 10-Q/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2008 · 25 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2007 · 30 filings — 24 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 26 filings — 20 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 26 filings — 20 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 20 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2003 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2002 · 9 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2001 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 8 filings — 4 × 8-K, 3 × 10-Q, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 74 filings — 44 × 4, 23 × 144, 2 × SCHEDULE 13D/A and 3 other forms
| Filed | What it is |
|---|---|
| Aug 14, 2026SCHEDULE 13D/A | Other filings |
| Aug 12, 20264 | Insider transaction (Form 4) |
| Aug 12, 2026SCHEDULE 13G/A | Other filings |
| Aug 10, 2026144 | Notice of proposed sale (Form 144) |
| Aug 5, 2026S-8 | Employee stock plan registration |
| Jun 3, 20264 | Insider transaction (Form 4) |
| Jun 3, 20264 | Insider transaction (Form 4) |
| Jun 1, 2026144 | Notice of proposed sale (Form 144) |
| Jun 1, 2026144 | Notice of proposed sale (Form 144) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 29, 20264 | Insider transaction (Form 4) |
| May 28, 20264 | Insider transaction (Form 4) |
| May 26, 2026144 | Notice of proposed sale (Form 144) |
| May 22, 20264 | Insider transaction (Form 4) |
| May 20, 2026144 | Notice of proposed sale (Form 144) |
| May 19, 20264 | Insider transaction (Form 4) |
| May 19, 20264 | Insider transaction (Form 4) |
The newest 25 of 74 shown; the full year is on EDGAR.
2025 · 102 filings — 67 × 4, 31 × 144, 2 × SCHEDULE 13D/A and 2 other forms
| Filed | What it is |
|---|---|
| Dec 12, 2025144 | Notice of proposed sale (Form 144) |
| Dec 5, 20254 | Insider transaction (Form 4) |
| Nov 26, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 20, 20253 | Initial insider holdings (Form 3) |
| Nov 20, 2025144 | Notice of proposed sale (Form 144) |
| Nov 19, 20254 | Insider transaction (Form 4) |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 13, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Oct 10, 20254 | Insider transaction (Form 4) |
| Jun 4, 20254 | Insider transaction (Form 4) |
| Jun 4, 20254 | Insider transaction (Form 4) |
| Jun 3, 2025144 | Notice of proposed sale (Form 144) |
| Jun 2, 20254 | Insider transaction (Form 4) |
| Jun 2, 2025144 | Notice of proposed sale (Form 144) |
| May 30, 20254 | Insider transaction (Form 4) |
| May 30, 20254 | Insider transaction (Form 4) |
The newest 25 of 102 shown; the full year is on EDGAR.
2024 · 99 filings — 64 × 4, 23 × 144, 3 × CORRESP and 6 other forms
| Filed | What it is |
|---|---|
| Dec 23, 20244 | Insider transaction (Form 4) |
| Dec 2, 20244 | Insider transaction (Form 4) |
| Nov 29, 2024144 | Notice of proposed sale (Form 144) |
| Nov 26, 20244 | Insider transaction (Form 4) |
| Nov 22, 2024144 | Notice of proposed sale (Form 144) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 19, 20244 | Insider transaction (Form 4) |
| Nov 18, 2024144 | Notice of proposed sale (Form 144) |
| Nov 18, 2024144 | Notice of proposed sale (Form 144) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 5, 2024144 | Notice of proposed sale (Form 144) |
| Nov 1, 20244 | Insider transaction (Form 4) |
| Nov 1, 20244 | Insider transaction (Form 4) |
| Nov 1, 2024144 | Notice of proposed sale (Form 144) |
| Nov 1, 2024144 | Notice of proposed sale (Form 144) |
| Oct 30, 20244 | Insider transaction (Form 4) |
| Oct 30, 2024144 | Notice of proposed sale (Form 144) |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Oct 3, 20244 | Insider transaction (Form 4) |
The newest 25 of 99 shown; the full year is on EDGAR.
2023 · 87 filings — 59 × 4, 9 × 144, 6 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2022 · 64 filings — 50 × 4, 5 × SC 13G/A, 4 × 5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2021 · 91 filings — 83 × 4, 3 × CT ORDER, 3 × SC 13G/A and 2 other forms
Counted, not listed; the year is on EDGAR.
2020 · 109 filings — 102 × 4, 3 × SC 13G/A, 2 × CT ORDER and 2 other forms
Counted, not listed; the year is on EDGAR.
2019 · 104 filings — 97 × 4, 6 × SC 13G/A, 1 × CT ORDER
Counted, not listed; the year is on EDGAR.
2018 · 110 filings — 74 × 4, 17 × S-8 POS, 7 × CT ORDER and 4 other forms
Counted, not listed; the year is on EDGAR.
2017 · 72 filings — 57 × 4, 6 × CT ORDER, 6 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2016 · 71 filings — 50 × 4, 8 × SC 13G/A, 6 × CT ORDER and 4 other forms
Counted, not listed; the year is on EDGAR.
2015 · 50 filings — 24 × 4, 8 × SC 13G/A, 6 × CT ORDER and 9 other forms
Counted, not listed; the year is on EDGAR.
2014 · 65 filings — 28 × 4, 13 × S-8 POS, 12 × SC 13G/A and 7 other forms
Counted, not listed; the year is on EDGAR.
2013 · 60 filings — 47 × 4, 7 × SC 13G/A, 5 × CT ORDER and 1 other form
Counted, not listed; the year is on EDGAR.
2012 · 71 filings — 40 × 4, 10 × CT ORDER, 6 × 424B5 and 6 other forms
Counted, not listed; the year is on EDGAR.
2011 · 67 filings — 41 × 4, 11 × S-8 POS, 7 × CT ORDER and 5 other forms
Counted, not listed; the year is on EDGAR.
2010 · 30 filings — 20 × 4, 3 × SC 13G/A, 2 × CT ORDER and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 60 filings — 34 × 4, 4 × SC 13G/A, 3 × CT ORDER and 13 other forms
Counted, not listed; the year is on EDGAR.
2008 · 68 filings — 32 × 4, 7 × CORRESP, 6 × CT ORDER and 10 other forms
Counted, not listed; the year is on EDGAR.
2007 · 71 filings — 61 × 4, 4 × SC 13G/A, 2 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2006 · 97 filings — 79 × 4, 5 × SC 13G/A, 3 × SC 13G and 7 other forms
Counted, not listed; the year is on EDGAR.
2005 · 72 filings — 52 × 4, 3 × 3, 3 × SC 13G/A and 11 other forms
Counted, not listed; the year is on EDGAR.
2004 · 79 filings — 65 × 4, 4 × 3, 3 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2003 · 144 filings — 130 × 4, 4 × SC 13G/A, 3 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2002 · 18 filings — 7 × 4, 3 × SC 13G/A, 2 × 424B3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2001 · 22 filings — 4 × 425, 4 × SC TO-T/A, 3 × S-3 and 7 other forms
Counted, not listed; the year is on EDGAR.
2000 · 19 filings — 5 × S-1/A, 2 × 425, 2 × S-8 and 9 other forms
Counted, not listed; the year is on EDGAR.
About this data#
Exelixis Inc. (EXEL) has 2,513 filings on EDGAR going back to 2000: 27 annual reports, 86 quarterly reports and 344 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Jan 2, 2026. The most recent 8-K, on Sep 11, 2026, covered other events. Over the last 13 months insiders sold $31.8M in 21 sales and bought nothing on the open market; 53 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Exelixis Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read EXEL's latest 10-K?
- EXEL's latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Jan 2, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did EXEL last file an 8-K?
- On Sep 11, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 5, 2026.
- Are EXEL insiders buying or selling?
- Over the last 13 months insiders sold $31.8M in 21 sales and bought nothing on the open market; 53 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Beckerle Mary C (Director) sold 9,812 shares on Aug 10, 2026 for $527K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has EXEL made?
- 2,513 filings are on EDGAR under the registrant records that have been Exelixis Inc., going back to 2000; 1,544 of them are insider ownership forms (Forms 3, 4, 5 and 144).
